241 related articles for article (PubMed ID: 33077922)
1. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma.
Momeni-Boroujeni A; Mohammad N; Wolber R; Yip S; Köbel M; Dickson BC; Hensley ML; Leitao MM; Antonescu CR; Benayed R; Ladanyi M; Lee CH; Chiang S
Mod Pathol; 2021 May; 34(5):1008-1016. PubMed ID: 33077922
[TBL] [Abstract][Full Text] [Related]
2. High-grade Endometrial Stromal Sarcoma: Morphologic and Clinical Features, the Role of Immunohistochemistry and Fluorescence in Situ Hybridization in Diagnosis.
Alkanat NE; Uner A; Usubutun A
Int J Surg Pathol; 2023 Aug; 31(5):521-531. PubMed ID: 35506912
[No Abstract] [Full Text] [Related]
3. Endometrial stromal sarcomas with BCOR-rearrangement harbor MDM2 amplifications.
Kommoss FK; Chang KT; Stichel D; Banito A; Jones DT; Heilig CE; Fröhling S; Sahm F; Stenzinger A; Hartmann W; Mechtersheimer G; Sinn HP; Schmidt D; Kommoss F; von Deimling A; Koelsche C
J Pathol Clin Res; 2020 Jul; 6(3):178-184. PubMed ID: 32352245
[TBL] [Abstract][Full Text] [Related]
4. Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.
Cotzia P; Benayed R; Mullaney K; Oliva E; Felix A; Ferreira J; Soslow RA; Antonescu CR; Ladanyi M; Chiang S
Am J Surg Pathol; 2019 May; 43(5):662-669. PubMed ID: 30789359
[TBL] [Abstract][Full Text] [Related]
5. Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications.
Kommoss FKF; Chiang S; Köbel M; Koelsche C; Chang KT; Irving JA; Dickson B; Thiryayi S; Rouzbahman M; Rasty G; von Deimling A; Lee CH; Turashvili G
Am J Surg Pathol; 2022 Aug; 46(8):1142-1152. PubMed ID: 35499168
[TBL] [Abstract][Full Text] [Related]
6. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology.
Chiang S; Lee CH; Stewart CJR; Oliva E; Hoang LN; Ali RH; Hensley ML; Arias-Stella JA; Frosina D; Jungbluth AA; Benayed R; Ladanyi M; Hameed M; Wang L; Kao YC; Antonescu CR; Soslow RA
Mod Pathol; 2017 Sep; 30(9):1251-1261. PubMed ID: 28621321
[TBL] [Abstract][Full Text] [Related]
7. BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas.
Mariño-Enriquez A; Lauria A; Przybyl J; Ng TL; Kowalewska M; Debiec-Rychter M; Ganesan R; Sumathi V; George S; McCluggage WG; Nucci MR; Lee CH; Fletcher JA
Am J Surg Pathol; 2018 Mar; 42(3):335-341. PubMed ID: 29200103
[TBL] [Abstract][Full Text] [Related]
8. ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity.
Lewis N; Soslow RA; Delair DF; Park KJ; Murali R; Hollmann TJ; Davidson B; Micci F; Panagopoulos I; Hoang LN; Arias-Stella JA; Oliva E; Young RH; Hensley ML; Leitao MM; Hameed M; Benayed R; Ladanyi M; Frosina D; Jungbluth AA; Antonescu CR; Chiang S
Mod Pathol; 2018 Apr; 31(4):674-684. PubMed ID: 29192652
[TBL] [Abstract][Full Text] [Related]
9. Uterine Endometrial Stromal Tumors With Pure Low-Grade Morphology Harboring YWHAE::NUTM2 Fusions: Report of a Case Series Emphasizing Potential for High-Grade Transformation and Aggressive Behavior.
Devins KM; Attygalle AD; Croce S; Vroobel K; Oliva E; McCluggage WG
Am J Surg Pathol; 2023 Jun; 47(6):717-724. PubMed ID: 37032555
[TBL] [Abstract][Full Text] [Related]
10. NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma.
Chiang S; Cotzia P; Hyman DM; Drilon A; Tap WD; Zhang L; Hechtman JF; Frosina D; Jungbluth AA; Murali R; Park KJ; Soslow RA; Oliva E; Iafrate AJ; Benayed R; Ladanyi M; Antonescu CR
Am J Surg Pathol; 2018 Jun; 42(6):791-798. PubMed ID: 29553955
[TBL] [Abstract][Full Text] [Related]
11. Highly Invasive and Metastatic High-grade Endometrial Stromal Sarcoma With
Ling F; Ruan S; Chen H; Xiong X; Zhao D; Haybaeck J; Zhang C
In Vivo; 2022; 36(4):1971-1976. PubMed ID: 35738637
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological study of BCOR rearrangement in high grade endometrial stromal sarcoma].
Cheng YF; Bai QM; Bi R; Chang B; Huang D; Yu L; Zhou XY; Yang WT; Tu XY
Zhonghua Bing Li Xue Za Zhi; 2019 Aug; 48(8):604-609. PubMed ID: 31422590
[No Abstract] [Full Text] [Related]
13. Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss.
Lin DI; Hemmerich A; Edgerly C; Duncan D; Severson EA; Huang RSP; Ramkissoon SH; Connor YD; Shea M; Hecht JL; Ali SM; Vergilio JA; Ross JS; Elvin JA
Gynecol Oncol; 2020 May; 157(2):357-366. PubMed ID: 32156473
[TBL] [Abstract][Full Text] [Related]
14. NTRK3 overexpression in undifferentiated sarcomas with YWHAE and BCOR genetic alterations.
Kao YC; Sung YS; Argani P; Swanson D; Alaggio R; Tap W; Wexler L; Dickson BC; Antonescu CR
Mod Pathol; 2020 Jul; 33(7):1341-1349. PubMed ID: 32034283
[TBL] [Abstract][Full Text] [Related]
15. YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlations.
Croce S; Hostein I; Ribeiro A; Garbay D; Velasco V; Stoeckle E; Guyon F; Floquet A; Neuville A; Coindre JM; MacGrogan G; Chibon F
Mod Pathol; 2013 Oct; 26(10):1390-400. PubMed ID: 23599159
[TBL] [Abstract][Full Text] [Related]
16. Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal Sarcoma.
Kang N; Zhang Y; Guo S; Chen R; Kong F; Wang S; Yuan M; Chen R; Shen D; Wang J
Cancer Res Treat; 2023 Jul; 55(3):978-991. PubMed ID: 36731460
[TBL] [Abstract][Full Text] [Related]
17. Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese clinical oncology group.
Yoshida H; Kikuchi A; Tsuda H; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Shikama A; Kogata Y; Terao Y; Tanikawa M; Yasuoka T; Chiyoda T; Miyamoto T; Okadome M; Nakamura T; Enomoto T; Konno Y; Yahata H; Hirata Y; Aoki Y; Tokunaga H; Usui H; Yaegashi N
Hum Pathol; 2022 Jun; 124():24-35. PubMed ID: 35339567
[TBL] [Abstract][Full Text] [Related]
18. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.
Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Belda MALF; Averous G; Leroux A; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
Gynecol Oncol; 2022 Nov; 167(2):373-389. PubMed ID: 36114030
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement.
Lee CH; Ali RH; Rouzbahman M; Marino-Enriquez A; Zhu M; Guo X; Brunner AL; Chiang S; Leung S; Nelnyk N; Huntsman DG; Blake Gilks C; Nielsen TO; Dal Cin P; van de Rijn M; Oliva E; Fletcher JA; Nucci MR
Am J Surg Pathol; 2012 Oct; 36(10):1562-70. PubMed ID: 22982899
[TBL] [Abstract][Full Text] [Related]
20. Description of a Novel ERBB4 -rearranged Uterine Sarcoma.
Lim SH; Mansor SB; Kathirvel R; Kuick CH; Lim-Tan SK; McCluggage WG
Int J Gynecol Pathol; 2022 Sep; 41(5):508-513. PubMed ID: 34570017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
